Overview
- 4 inspections across 4 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-09-18.
At a glance
Inspections
4
Sites
4
Observations
0
Career since
Jul 2024
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Biotechpharma, Biotechnologines Farmacijos Centras UAB | 18 Sep 2025 | Human Drugs | On file |
| Genzyme Ireland Limited | 17 Jan 2025 | Human Drugs | On file |
| Sharp Sterile Manufacturing, LLC | 21 Oct 2024 | Human Drugs | On file |
| Samsung Biologics Co., Ltd. | 30 Jul 2024 | Human Drugs | On file |
Sites inspected
Biotechpharma, Biotechnologines Farmacijos Centras UABVerkiai, Lithuania1 insp.
Genzyme Ireland LimitedWaterford, Ireland1 insp.
Sharp Sterile Manufacturing, LLCLee, United States1 insp.
Samsung Biologics Co., Ltd.Yeonsu District, Korea (the Republic of)1 insp.
Co-investigators
Investigators who share inspections with this person.
Melissa D Ray1 shared
Wayne E Seifert1 shared
Charles Y Kuo1 shared
Yiwei Li1 shared
Hamet M Toure1 shared
Zhong Li1 shared
Cassandra L Abellard1 shared
Full investigator report
Get the verbatim findings behind Andrea Franco's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site